Basic information Uses Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Pyrimidines >  Methoxy-pyrimidine >  Pyrimidine, 4-chloro-5-methoxy- (6CI,7CI,8CI,9CI)

Pyrimidine, 4-chloro-5-methoxy- (6CI,7CI,8CI,9CI)

Basic information Uses Safety Supplier Related

Pyrimidine, 4-chloro-5-methoxy- (6CI,7CI,8CI,9CI) Basic information

Product Name:
Pyrimidine, 4-chloro-5-methoxy- (6CI,7CI,8CI,9CI)
Synonyms:
  • Pyrimidine, 4-chloro-5-methoxy- (6CI,7CI,8CI,9CI)
  • 4-Chloro-5-methoxypyrimidine
  • Pyrimidine, 4-chloro-5-methoxy-
  • Pyrimidine, 4-chloro-5-methoxy- (6CI,7CI,8CI,9CI) ISO 9001:2015 REACH
CAS:
695-85-2
MF:
C5H5ClN2O
MW:
144.56
Product Categories:
  • PYRIMIDINE
Mol File:
695-85-2.mol
More
Less

Pyrimidine, 4-chloro-5-methoxy- (6CI,7CI,8CI,9CI) Chemical Properties

Melting point:
63-64℃
Boiling point:
221.9±20.0 °C(Predicted)
Density 
1.292±0.06 g/cm3(Predicted)
storage temp. 
under inert gas (nitrogen or Argon) at 2-8°C
pka
0.17±0.16(Predicted)
Appearance
White to yellow Solid
InChI
InChI=1S/C5H5ClN2O/c1-9-4-2-7-3-8-5(4)6/h2-3H,1H3
InChIKey
CTMIYYREUVYVEL-UHFFFAOYSA-N
SMILES
C1=NC=C(OC)C(Cl)=N1
More
Less

Safety Information

HS Code 
2933599590
More
Less

Pyrimidine, 4-chloro-5-methoxy- (6CI,7CI,8CI,9CI) Usage And Synthesis

Uses

4-Chloro-5-methoxypyrimidine is a heterocyclic compound that can be used as an intermediate in organic synthesis.

Synthesis

695-87-4

695-85-2

The general procedure for the synthesis of 4-chloro-5-methoxypyrimidine from 4-hydroxy-5-methoxypyrimidine was as follows: 5-methoxypyrimidin-4-ol (57 g, 0.452 mol) was suspended in phosphorous triclosan (540 mL) and heated to reflux for 6 hours. The progress of the reaction was monitored by thin layer chromatography (TLC, unfolding agent dichloromethane/methanol = 10:1), and after confirming the completion of the reaction, most of the phosphorous trichloride was evaporated under reduced pressure. The residue was slowly poured into ice water (2 L) and the pH was adjusted with potassium carbonate (250 g) to about 7. Subsequently, the mixture was extracted with ethyl acetate/tert-butyl methyl ether (3:1, 4 x 250 mL). The organic phases were combined, washed with brine (100 mL), dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to give 4-chloro-5-methoxypyrimidine (3S g, 58% yield) as a yellow solid. Its 1H NMR (400 MHz, DMSO-d6) data were as follows: δ 8.63 (s, 1H), 8.32 (s, 1H), 4.02 (s, 3H).

References

[1] Journal of Organic Chemistry, 1997, vol. 62, # 26, p. 9192 - 9202
[2] Patent: WO2016/97918, 2016, A1. Location in patent: Page/Page column 80
[3] Organic Process Research and Development, 2015, vol. 19, # 6, p. 639 - 645

Pyrimidine, 4-chloro-5-methoxy- (6CI,7CI,8CI,9CI)Supplier

Nanjing Asfam Pharmaceutical Technology Co., Ltd. Gold
Tel
025-58867862 18751812725
Email
sales@ace-pharm.com
BeiJing Hwrk Chemicals Limted
Tel
0757-86329057 18934348241
Email
sales4.gd@hwrkchemical.com
Carbott PharmTech Inc.
Tel
0535-6385396
Email
info@carbottpharm.com
Nanjing Habo Medical Technology Co., Ltd.
Tel
025-85760892 13376080562
Email
sales@habotech.com
Pure Chemistry Scientific Inc.
Tel
001-857-928-2050 or 1-888-588-9418
Email
sales@chemreagents.com